Application of multiplex arrays for cytokine and chemokine profiling of bile.

[1]  M. Schiffman,et al.  Evaluation of a multiplex panel of immune‐related markers in cervical secretions: A methodologic study , 2014, International journal of cancer.

[2]  R. Pfeiffer,et al.  Circulating inflammation markers and prospective risk for lung cancer. , 2013, Journal of the National Cancer Institute.

[3]  N. Rothman,et al.  A prospective study of 67 serum immune and inflammation markers and risk of non-Hodgkin lymphoma. , 2013, Blood.

[4]  L. McShane,et al.  Circulating levels of immune and inflammatory markers and long versus short survival in early-stage lung cancer. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  T. Berg,et al.  Increased T-helper 2 cytokines in bile from patients with IgG4-related cholangitis disrupt the tight junction-associated biliary epithelial cell barrier. , 2013, Gastroenterology.

[6]  H. Rodríguez-Hernández,et al.  Obesity and Inflammation: Epidemiology, Risk Factors, and Markers of Inflammation , 2013, International journal of endocrinology.

[7]  Seth D. Crockett,et al.  Burden of gastrointestinal disease in the United States: 2012 update. , 2012, Gastroenterology.

[8]  Y. Eby,et al.  Comparison of normalization methods for measuring immune markers in cervical secretion specimens. , 2012, Journal of immunological methods.

[9]  J. P. McCoy,et al.  Evaluation of Multiplexed Cytokine and Inflammation Marker Measurements: a Methodologic Study , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[10]  E. Maury,et al.  Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome , 2010, Molecular and Cellular Endocrinology.

[11]  Jinbo Chen,et al.  Gallstones and the risk of biliary tract cancer: a population-based study in China , 2007, British Journal of Cancer.

[12]  Laura Herrero,et al.  Obesity, inflammation, and insulin resistance. , 2007, Gastroenterology.

[13]  P. Burgel,et al.  MUC5AC, a gel-forming mucin accumulating in gallstone disease, is overproduced via an epidermal growth factor receptor pathway in the human gallbladder. , 2006, The American journal of pathology.

[14]  J. Fraumeni,et al.  Aspirin Use and Risk of Biliary Tract Cancer: A Population-Based Study in Shanghai, China , 2005, Cancer Epidemiology Biomarkers & Prevention.

[15]  Troels Z. Kristiansen,et al.  Mac‐2‐binding protein is a diagnostic marker for biliary tract carcinoma , 2004, Cancer.

[16]  I. Wistuba,et al.  Gallbladder cancer: lessons from a rare tumour , 2004, Nature Reviews Cancer.

[17]  Satnam Singh,et al.  C-reactive protein in patients with gallbladder and biliary tract diseases. , 2004, Tropical gastroenterology : official journal of the Digestive Diseases Foundation.

[18]  B. Kendall,et al.  Biliary Interleukin-6 and Tumor Necrosis Factor-α in Patients Undergoing Endoscopic Retrograde Cholangiopancreatography , 1997, Digestive Diseases and Sciences.

[19]  L. Johnson.  Encyclopedia of Gastroenterology , 2004 .

[20]  Y. Gong,et al.  Transforming growth factor-beta (TGF-beta) protein levels are not elevated in the blood or bile of patients with primary sclerosing cholangitis: a pilot study. , 2004, Digestive diseases and sciences.

[21]  Y. Gong,et al.  Transforming Growth Factor-β (TGF-β) Protein Levels Are Not Elevated in the Blood or Bile of Patients with Primary Sclerosing Cholangitis: A Pilot Study , 2004, Digestive Diseases and Sciences.

[22]  W. Hop,et al.  Early differentiation between rejection and infection in liver transplant patients by serum and biliary cytokine patterns , 2003, Transplantation.

[23]  Y. Seyama,et al.  Matrix metalloproteinase-2 and -9 in bile as a marker of liver metastasis in colorectal cancer. , 2001, Biochemical and biophysical research communications.

[24]  A. Csendes,et al.  Number and size of stones in patients with asymptomatic and symptomatic gallstones and gallbladder carcinoma: A prospective study of 592 cases , 2000, Journal of Gastrointestinal Surgery.

[25]  A. Michalski,et al.  Accuracy of t-PA, u-PA, PAI-1 and PAI-2 estimation in human bile by ELISA kits. , 2000, Medical science monitor : international medical journal of experimental and clinical research.

[26]  L. Belov,et al.  Western blot analysis of bile or intestinal fluid from patients with septic shock or systemic inflammatory response syndrome, using antibodies to TNF‐α, IL‐1α and IL‐1β , 1999 .

[27]  R. Miller,et al.  Western blot analysis of bile or intestinal fluid from patients with septic shock or systemic inflammatory response syndrome, using antibodies to TNF-alpha, IL-1 alpha and IL-1 beta. , 1999, Immunology and cell biology.

[28]  T. Juvonen.  Pathogenesis of gallstones. , 1994, Scandinavian journal of gastroenterology.

[29]  J. Neuberger,et al.  DETECTION OF CIRCULATING INTERCELLULAR ADHESION MOLECULE‐1 AFTER LIVER TRANSPLANTATION‐EVIDENCE OF LOCAL RELEASE WITHIN THE LIVER DURING GRAFT REJECTION , 1993, Transplantation.

[30]  J. Neuberger,et al.  SOLUBLE INTERLEUKIN-2 RECEPTORS IN SERUM AND BILE OF LIVER TRANSPLANT RECIPIENTS , 1989, The Lancet.

[31]  J. Lamont,et al.  Identification of gallbladder mucin-bilirubin complex in human cholesterol gallstone matrix. Effects of reducing agents on in vitro dissolution of matrix and intact gallstones. , 1985, The Journal of clinical investigation.

[32]  A. Diehl.  Gallstone size and the risk of gallbladder cancer. , 1983, JAMA.